BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 29140481)

  • 1. Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
    Robak LA; Jansen IE; van Rooij J; Uitterlinden AG; Kraaij R; Jankovic J; ; Heutink P; Shulman JM
    Brain; 2017 Dec; 140(12):3191-3203. PubMed ID: 29140481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
    Blauwendraat C; Reed X; Krohn L; Heilbron K; Bandres-Ciga S; Tan M; Gibbs JR; Hernandez DG; Kumaran R; Langston R; Bonet-Ponce L; Alcalay RN; Hassin-Baer S; Greenbaum L; Iwaki H; Leonard HL; Grenn FP; Ruskey JA; Sabir M; Ahmed S; Makarious MB; Pihlstrøm L; Toft M; van Hilten JJ; Marinus J; Schulte C; Brockmann K; Sharma M; Siitonen A; Majamaa K; Eerola-Rautio J; Tienari PJ; ; Pantelyat A; Hillis AE; Dawson TM; Rosenthal LS; Albert MS; Resnick SM; Ferrucci L; Morris CM; Pletnikova O; Troncoso J; Grosset D; Lesage S; Corvol JC; Brice A; Noyce AJ; Masliah E; Wood N; Hardy J; Shulman LM; Jankovic J; Shulman JM; Heutink P; Gasser T; Cannon P; Scholz SW; Morris H; Cookson MR; Nalls MA; Gan-Or Z; Singleton AB
    Brain; 2020 Jan; 143(1):234-248. PubMed ID: 31755958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of rare damaging variants in hereditary atypical parkinsonism genes is increased in patients with Parkinson's disease.
    Kim YJ; Lee J; Kim NY; Hong S; Cho YS; Yoon J
    Neurobiol Aging; 2021 Apr; 100():118.e5-118.e13. PubMed ID: 33423827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Analysis of Prosaposin, the Lysosomal Storage Disorder Gene in Parkinson's Disease.
    Chen YP; Gu XJ; Ou RW; Zhang LY; Hou YB; Liu KC; Cao B; Wei QQ; Song W; Zhao B; Wu Y; Cheng JQ; Shang HF
    Mol Neurobiol; 2021 Apr; 58(4):1583-1592. PubMed ID: 33219486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
    Shachar T; Lo Bianco C; Recchia A; Wiessner C; Raas-Rothschild A; Futerman AH
    Mov Disord; 2011 Aug; 26(9):1593-604. PubMed ID: 21618611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Berge-Seidl V; Pihlstrøm L; Maple-Grødem J; Forsgren L; Linder J; Larsen JP; Tysnes OB; Toft M
    Neurosci Lett; 2017 Sep; 658():48-52. PubMed ID: 28830825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.
    Ysselstein D; Shulman JM; Krainc D
    Mov Disord; 2019 May; 34(5):614-624. PubMed ID: 30726573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
    Neumann J; Bras J; Deas E; O'Sullivan SS; Parkkinen L; Lachmann RH; Li A; Holton J; Guerreiro R; Paudel R; Segarane B; Singleton A; Lees A; Hardy J; Houlden H; Revesz T; Wood NW
    Brain; 2009 Jul; 132(Pt 7):1783-94. PubMed ID: 19286695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk.
    Straniero L; Rimoldi V; Monfrini E; Bonvegna S; Melistaccio G; Lake J; Soldà G; Aureli M; Shankaracharya ; Keagle P; Foroud T; Landers JE; Blauwendraat C; Zecchinelli A; Cilia R; Di Fonzo A; Pezzoli G; Duga S; Asselta R
    Mov Disord; 2022 Jun; 37(6):1202-1210. PubMed ID: 35262230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort.
    Graham OEE; Pitcher TL; Liau Y; Miller AL; Dalrymple-Alford JC; Anderson TJ; Kennedy MA
    Parkinsonism Relat Disord; 2020 Jan; 70():36-41. PubMed ID: 31809948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews.
    Dagan E; Schlesinger I; Ayoub M; Mory A; Nassar M; Kurolap A; Peretz-Aharon J; Gershoni-Baruch R
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1067-71. PubMed ID: 26169695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.
    Rudakou U; Yu E; Krohn L; Ruskey JA; Asayesh F; Dauvilliers Y; Spiegelman D; Greenbaum L; Fahn S; Waters CH; Dupré N; Rouleau GA; Hassin-Baer S; Fon EA; Alcalay RN; Gan-Or Z
    Brain; 2021 Mar; 144(2):462-472. PubMed ID: 33349842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
    McNeill A; Magalhaes J; Shen C; Chau KY; Hughes D; Mehta A; Foltynie T; Cooper JM; Abramov AY; Gegg M; Schapira AH
    Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease.
    Foo JN; Liany H; Bei JX; Yu XQ; Liu J; Au WL; Prakash KM; Tan LC; Tan EK
    Neurobiol Aging; 2013 Dec; 34(12):2890.e13-5. PubMed ID: 23871123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic convergence of Parkinson's disease and lysosomal storage disorders.
    Deng H; Xiu X; Jankovic J
    Mol Neurobiol; 2015; 51(3):1554-68. PubMed ID: 25099932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
    Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMPD1 variants in Chinese Han patients with sporadic Parkinson's disease.
    Mao CY; Yang J; Wang H; Zhang SY; Yang ZH; Luo HY; Li F; Shi M; Liu YT; Zhuang ZP; Du P; Wang YH; Shi CH; Xu YM
    Parkinsonism Relat Disord; 2017 Jan; 34():59-61. PubMed ID: 27814975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
    Barkhuizen M; Anderson DG; Grobler AF
    Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.